News

Blog News

Vaccine patent waiver breaks faith with American companies, stifles innovation
News,
Vaccine patent waiver breaks faith with American companies, stifles innovation

Vaccine patent waiver breaks faith with American companies, stifles innovation NCBIO is extremely disappointed that the Biden administration has chosen to support waiving critical intellectual property protections for U.S. COVID-19 vaccines. This decision, known as a TRIPS waiver,... Continue Reading

Date posted05/13/2021